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Background
One small prospective series and two single case reports
had described successful treatment of primary depersonal-
ization disorder in a number of patients treated with
fluoxetine [1-3]. But then, one recent randomized, double
masked, placebo-controlled trial failed to show efficacy
[4]. We present the case of depersonalization disorder that
responded favorably to fluoxetine treatment.
Materials and methods
A 23-year old single man had a 1-year history of primary
depersonalization disorder. He described feeling
“detached from my body, as if I was observing myself
from the outside, cut off from emotions and feelings, feel-
ing as if I had completely lost my self and feeling like I was
in a dream”. He felt far removed from everything. The
patient was treated with fluoxetine 10 mg/day, which was
slowly raised to 40 mg/day.
Results
Eight weeks after beginning fluoxetine, the patient had a
remarkable improvement. Following complete resolution
of the depersonalization symptoms, the patient began to
socialize, entertain and work. This is continued for 12
months of follow up.
Conclusions
Fluoxetine may be a promising pharmacological treat-
ment for primary depersonalization disorder.
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